SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034438
Filing Date
2024-03-21
Accepted
2024-03-21 08:33:48
Documents
62
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K labp-20231231.htm   iXBRL 10-K 1854537
2 EX-23.1 labp-ex23_1.htm EX-23.1 7133
3 EX-31.1 labp-ex31_1.htm EX-31.1 16202
4 EX-32.1 labp-ex32_1.htm EX-32.1 8151
5 EX-97.1 labp-ex97_1.htm EX-97.1 53474
6 GRAPHIC img111786952_0.jpg GRAPHIC 71233
7 GRAPHIC img111786952_1.jpg GRAPHIC 64815
8 GRAPHIC img111786952_2.jpg GRAPHIC 26783
9 GRAPHIC img111786952_3.jpg GRAPHIC 23377
  Complete submission text file 0000950170-24-034438.txt   7730397

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT labp-20231231.xsd EX-101.SCH 1214123
66 EXTRACTED XBRL INSTANCE DOCUMENT labp-20231231_htm.xml XML 975096
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39971 | Film No.: 24769594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)